|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910954143803321 |
|
|
Titolo |
Breakthrough business models : drug development for rare and neglected diseases and individualized therapies : workshop summary / / Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Health Sciences Policy, Institute of Medicine of the National Academies |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Washington, D.C., : National Academies Press, 2009 |
|
|
|
|
|
|
|
ISBN |
|
9786612083556 |
9780309178167 |
0309178169 |
9781282083554 |
1282083554 |
9780309120890 |
0309120896 |
|
|
|
|
|
|
|
|
Edizione |
[1st ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (149 p.) |
|
|
|
|
|
|
Altri autori (Persone) |
|
WizemannTheresa M |
RobinsonSally |
GiffinRobert B |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Orphan drugs - Government policy - United States |
Pharmaceutical policy - United States |
Drugs - Design - United States |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Bibliographic Level Mode of Issuance: Monograph |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references (p. 104-105). |
|
|
|
|
|
|
Nota di contenuto |
|
Introduction and overview -- Current model for financing drug development : from concept through approval -- The Food and Drug Administration's Orphan Drug Program -- Diverse funding models -- Strategies for facilitating sharing of research materials and data -- Strategies of navigation intellectual property -- Strategies for facilitating clinical trials -- Summary. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
"The Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop on June 23, 2008, titled "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies." The purpose of the |
|
|
|
|